Recent studies demonstrate a significant increase in the prevalence of allergic diseases in industrialized countries and underline the multifactorial cause of allergy. [1] [2] [3] Genetic inheritance was reported as one of the potential causes of allergy. The allergic reaction is characterized by a disruption of the T H 1/T H 2 balance toward a pronounced T H 2 profile. Indeed, T H 2 lymphocytes, by producing IL-4, IL-5, IL-9, or IL-13, might play a pivotal role in the development and maintenance of the allergic response. 4 Moreover, newborn babies express a constitutive predominant T H 2 cytokine profile because of the in utero environment, in which high IL-4 and prostaglandin concentrations have been detected. 5 The abnormal maintenance of the T H 2 profile, which usually decreases with age, was considered as a lack of a sufficient T H 1 response development. 5 Modern hygiene rules, intensive food sterilization, 1 and modification of the gut flora of newborn babies 6 caused by feeding with artificial formula were reported as potential factors involved in the altered establishment in T H 1 regulatory response. 7, 8 Dietary lactic acid bacteria (LAB) are well known for their use in the preparation of fermented food products. Moreover, some species or strains have been attributed to potential health benefits or probiotic effects. [9] [10] [11] [12] [13] [14] These bacteria have been generally recognized as safe and have been consumed by persons or animals from time immemorial. Experiments carried out in mice sensitized to ovalbumin have clearly indicated that after gastric administration of LAB, the specific IgE and T H 2 profile-dependent inflammatory responses were inhibited. 15, 16 Moreover, recent reports suggest that Lactobacillus rhamnosus GG can reduce allergic disease symptoms in human subjects. The administration of this strain to breast-feeding mothers and to newborn babies led to a high inhibition (50%) of the risk of atopic eczema in babies. 17, 18 Recent in vitro experiments 19, 20 demonstrated that the stimulation of PBMCs or monocytes from healthy donors by a variety of LAB species enhanced the secretion of IL-12, which is a pivotal pro-T H 1 cytokine involved in the control of allergic disease development. However, the mechanism by which LAB might affect the production of T H 2 cytokines responsible for the initiation of the development of allergic disease remains to be
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Lactic acid bacteria inhibit T H 2 cytokine production by mononuclear cells from allergic patients specified. In this report we have analyzed the effect of 4 LAB strains on the T H 2 cytokine production by PBMCs from allergic patients sensitized to Dermatophagoides pteronyssinus or from healthy donors after stimulation with staphylococcal enterotoxin A (SEA) or the relevant aeroallergen D pteronyssinus. The studied LAB strains were shown to exhibit anti-T H 2 activities involving the participation of antigen-presenting cells (APCs) as monocytes and the pro-T H 1 cytokines IL-12 and IFN-γ.
METHODS Reagents
SEA was obtained from Sigma. Total extract of house dust mite (D pteronyssinus) was provided by Stallergenes SA.
Patients and healthy donors
Blood was collected from allergic patients sensitive to house dust mite. The allergic patients presented with a history of asthma and had specific IgE antibodies and positive skin prick test responses toward D pteronyssinus (RAST class >2). Their total IgE levels were greater than 150 kU/L. Healthy donors displayed total IgE levels of less than 50 kU/L and no D pteronyssinus-specific IgE in their sera (<0.35 kU/L).
Cell preparation
Blood was depleted from platelet-rich plasma and diluted in RPMI 1640 medium (Life Invitrogen). Human PBMCs were isolated by means of centrifugation (400g for 30 minutes) over a Ficoll density gradient (Pharmacia). After washing, cells were resuspended at a concentration of 2 × 10 6 cells/mL in RPMI 1640 medium containing 10% heat-inactivated FCS (Bio Media), 2 mmol/L L-glutamine, and 0.2 µg/mL Ticarpen (ticarcilline; SmithKline Beecham) to prevent bacterial overgrowth.
For T-cell, B-cell, and monocyte preparations, PBMCs were incubated on ice for 30 minutes with CD14 or CD19 antibodies coupled to magnetic microbeads (Miltenyi Biotec), washed, and applied onto a column placed in the magnetic field of a Macs separator (Miltenyi Biotec), according to the manufacturer's recommendations. CD14 + monocytes or CD19 + B cells were collected, washed, and conserved at 4°C before use. CD4 + T cells were purified by using the CD4 + T-cell isolation kit (containing CD8, CD11b, CD16, CD19, CD36, and CD56 antibodies), according to the manufacturer's recommendations.
Preparation of bacteria
Four types of LAB were used: Lactobacillus plantarum NCIMB8826 (LAB1), Lactococcus lactis MG1363 (LAB2), Lactobacillus casei ATCC393 (LAB3), and Lactobacillus rhamnosus GG (LAB4). Lactobacilli strains were grown at 37°C in MRS broth (Difco), and the lactococcal strain was cultured at 30°C in M17 supplemented with 0.5% glucose. Escherichia coli TG1 (TG1) was grown at 37°C in Luria-Bertani broth medium and used as the gramnegative bacteria strain control, as already reported. 21 LAB strains and TG1 were pregrown overnight in appropriate medium. Exponential phase cultures were obtained by means of dilution of the preculture at 1:20 for LAB and 1:50 for TG1 in fresh medium and further incubation under appropriate conditions until the logarithmic phase (as measured by OD at 600 nm). Bacteria were then washed 3 times with PBS and adjusted at a final concentration of 10 10 colony-forming units per milliliter. The bacterial suspensions were stored at -80°C in PBS solution containing 20% glycerol. The concentration of bacteria was determined by plating serial dilutions on the appropriate medium.
Heat-killed bacteria were prepared by means of a 1-hour incubation at 70°C. Alternatively, LAB were inactivated by a 15-minute incubation in paraformaldehyde (4%), followed by 3 washes in PBS. The absence of viable bacteria was checked by plating on the appropriate growth medium.
Activation of mononuclear cells
PBMCs (2 × 10 6 /mL) were stimulated with SEA (2 µg/mL) or D pteronyssinus allergen (1 IR/mL [index of reactivity-equivalent to approximately 2 µg of protein]). Three protocols were used to evaluate the effects of LAB on PBMCs: live LAB strains were added either (1) 3 hours before, (2) at the same time, or (3) 3 hours after the stimulation. In each case centrifuged supernatants were collected after 48 hours' incubation and stored at -20°C until use. It was verified that the low concentrations of the used antibiotic did not kill the bacteria but permitted maintenance of a constant number of viable bacterial cells throughout the incubation period with PBMCs. Moreover, some experiments were performed with killed LAB by using the first protocol. Purified monocytes or B lymphocytes were preincubated with LAB strains for 3 hours at a ratio of 10 bacteria per cell (10:1) in the presence of purified CD4 + T cells (2 × 10 6 /mL corresponding to a ratio of 10 T cells/monocyte), and then SEA or D pteronyssinus were added to the coculture to evaluate the involvement of APCs in the effect of LAB on lymphokine production. Supernatants were treated as described above. Control experiments were performed with anti-IL-12 and anti-IFN-γ antibodies (obtained from R&D Systems) to evaluate the involvement of IL-12, IFN-γ, or both on the effect induced by LAB.
Cytokine assays
IL-4 and IFN-γ were quantified in the supernatants by means of specific ELISA (Diaclone), whereas IL-5 ELISA was performed by using Pharmingen products, according to the manufacturer's recommendations. The sensitivity of the IL-4, IL-5, or IFN-γ assay was 0.5, 5, or 5 pg/mL, respectively.
Statistical analysis
Nonparametric statistical analyses were performed with the Mann-Whitney test. P values of less than .05 were considered statistically significant.
RESULTS

LAB specifically inhibit the IL-4 production from SEA-stimulated PBMCs of healthy donors and amplify IFN-γ secretion
Preliminary experiments have shown that PBMCs from healthy donors stimulated with a streptococcal superantigen (2 µg/mL) produced high levels of IL-4 and IL-5, 2 T H 2 cytokines usually associated with allergic disorders. Heat-killed LAB were able to downregulate this type 2 cytokine profile secretion. 22 In the present work we have confirmed these observations with a different superantigen: staphylococcal SEA.
When live strains of LAB were preincubated with PBMCs, the subsequent IL-4 production induced by SEA
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LAB: Lactic acid bacteria SEA: Staphylococcal enterotoxin A STAT: Signal transducer and activator of transcription was highly reduced when compared with that induced by positive controls (no preincubation with LAB). Interestingly, no significant inhibition was observed when PBMCs were preincubated with the gram-negative control strain TG1 (Fig 1, A) . Although neither the 2 LAB strains nor TG1 induced basic IL-4 production, all 3 strains triggered the secretion of IFN-γ. Moreover, when PBMCs were stimulated with SEA, the level of IFN-γ release was greatly increased, and a synergistic effect was observed not only with the LAB but also with TG1 (Fig 1, B) . Thus LAB appeared to be able to alter both T H 1 and T H 2 cytokine secretion in an opposite manner.
Parameters influencing cytokine production
Further experiments carried out with 4 LAB strains demonstrated that T H 2 cytokine inhibition was dependent on several parameters. When PBMCs were stimulated with LAB before adding SEA, the inhibitory effect on T H 2 cytokine production increased with the LAB/PBMC ratio (Fig 2, A and B) . This effect was similarly observed for IL-4 and IL-5 production. inhibition of IL-4 production in response to SEA increased from 46% ± 3% (1:1 ratio) to 57% ± 5% (10:1 ratio), and the percentage of inhibition of IL-5 production increased from 42% ± 9% (1:1 ratio) to 71% ± 1% (10:1 ratio). However, no significant difference was noticed among the 4 LAB strains used. In contrast to T H 2 cytokines, these LAB strains induced a basic production of IFN-γ, which seems to depend on the LAB/PBMC ratio. It is noteworthy that LAB were shown to strongly potentiate the IFN-γ production in response to SEA stimulation (Fig 2, C) . The reduction of IL-4 release was equivalent when the LAB were added simultaneously or subsequently to the SEA stimulus (Fig 3, A) . Moreover, the level of inhibition was not affected by the physiologic state of the bacteria because live bacteria induced the same effect as heat-killed or paraformaldehyde-treated LAB (Fig 3, B) .
LAB inhibit the T H 2 cytokine production of allergen-stimulated PBMCs from allergic patients
The ability of LAB to correct the imbalance between T H 1 and T H 2 cytokines was next evaluated in a more relevant model of stimulation by allergen. When PBMCs from patients allergic to D pteronyssinus were preincubated with different live LAB strains, the IL-4 and IL-5 production induced after specific D pteronyssinus allergen stimulation was largely reduced in an LAB/PBMC ratio-dependent manner. This effect was independent of the species-strains of LAB studied. For example, IL-5 inhibition was equal to 60% ± 2% for LAB1 and 62% ± 3% for LAB4 (L rhamnosus GG, 10:1 ratio; Fig 4, A and  B) . Similar effects were observed when PBMCs from allergic patients were stimulated with SEA. In this case although IL-4 and IL-5 production was very high compared with the production obtained with D pteronyssinus, LAB markedly reduced the IL-5 secretion by 73% ± 3% and 75% ± 3% for LAB1 and LAB4, respectively (data not shown). The coincubation with LAB strongly increased the production of IFN-γ (Fig 4, C) , which, in the presence of the related allergen, was less than 1 ng/mL.
Thus by reducing T H 2 cytokine production and by enhancing the IFN-γ production by PBMCs from allergic patients, LAB appeared to exhibit an anti-T H 2 activity.
Involvement of CD14 + monocytes in cytokine production
Experiments were carried out with different purified cell subpopulations to investigate the mechanism by which LAB are able to modify cytokine production. When purified human monocytes from healthy donors were preincubated with LAB and further cultivated in the presence of autologous T cells, followed by stimulation with SEA, IL-4 production was reduced to a level similar to that observed when total PBMCs were incubated with LAB in the presence of SEA superantigen (Fig 5,  A) . This inhibition effect was also observed with purified B cells, but the percentage of inhibition was slightly less pronounced than with monocytes (Fig 5, B) . These APCs do appear to be directly or indirectly involved in the inhibition of T H 2 cytokine release in response to LAB.
IL-12 and IFN-γ produced by LAB inhibit T H 2 cytokine production
LAB stimulation leads to the production of IL-12 and IFN-γ. Experiments were performed in the presence of neutralizing anti-IL-12 and anti-IFN-γ antibodies to appreciate the role of these 2 cytokines in the T H 2 cytokine inhibition effect. As shown in Fig 6, neutralization of these pro-T H 1 cytokines restored the IL-4 production inhibited by the LAB1 strain, suggesting that these 2 cytokines could be involved in the inhibition mechanism.
DISCUSSION
Allergic diseases are characterized by a type 2 cytokine profile expression. Indeed, IL-4, IL-5, IL-13, and IL-9 are involved in the initiation and maintenance of the allergic reaction. In this report we showed that different LAB strains belonging to various species can modulate the T H 1/T H 2 balance by reducing T H 2 cytokine release and enhancing T H 1 cytokine production (IFN-γ). Thus such LAB could exert a beneficial effect in patients with allergic asthma by means of their inhibitory effect on T H 2 cytokine production.
To demonstrate this effect, we first used a T H 2 cytokine-producing cellular model (ie, PBMCs stimulated with the superantigen SEA). Several reports indicate that PBMCs secrete T H 2 cytokines after stimulation with superantigens by using similar signaling pathways as those involved with usual antigens. 23 In our study, when PBMCs were preincubated with LAB, T H 2 cytokine production was reduced. As reported previously, 22 this inhibitory effect was obtained with all the tested grampositive LAB but not in the presence of the gram-negative bacterium E coli TG1. The inhibition was demonstrated to be dependent on the dose of LAB used, with higher bacterial doses leading to more pronounced reduction of IL-4 and IL-5 production. Such a doseresponse effect was reported in vitro for IL-10 and IL-12 release by monocytes from healthy donors on incubation with different strains of gram-positive bacteria. 20 We also demonstrated that the viability of bacteria was not 
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absolutely required for the inhibitory effect because heatkilled or paraformaldehyde-treated bacteria performed equally well as exponentially growing strains. Interestingly, the production of the T H 2 cytokines IL-4, IL-5, and IL-13 by PBMCs from allergic patients stimulated with the related allergen was found to be highly reduced when PBMCs were incubated in vitro with LAB. To the best of our knowledge, this is the first report of a beneficial effect of LAB on cells from patients sensitized to an aeroallergen. Indeed, previous reports are all related to allergic symptoms caused by food allergens. For example, Kalliomaki et al 18 described that after L rhamnosus GG oral supplementation for 8 weeks, children with atopic dermatitis and cow's milk allergy exhibit a transient early upregulation in IFN-γ production and a later decrease in IL-4 production. These observations correlate well with studies performed in mice in which specific LAB strains were shown to modify the T H 2 profile induced in response to ovalbumin or casein. In these experiments LAB reduced the IgE response, as well as the allergen-dependent inflammatory response. 15, 16, [24] [25] [26] Because the inhibitory effect was observed even when the LAB were added after SEA or D pteronyssinus stimulus (data not shown), our observations suggest that LAB might act by regulating directly or indirectly the signaling pathway required for T H 2 cytokine production. Several factors can modulate IL-4 and IL-5 release. Indeed, IFN-γ was described as a potential regulator of IL-4 synthesis. In addition, IL-12 was reported as a key cytokine in the initiation of IFN-γ production by human PBMCs. LAB were capable of inducing IL-12 secretion by PBMCs, as well as by monocytes (data not shown). In our experimental setting, APCs (ie, monocytes) were absolutely required to generate the inhibitory effect on IL-4 production. This effect mediated by APCs could either be due to bacteria phagocytosis, which is mainly associated with a type 1 response, or to the involvement of toll-like receptors, the stimulation of which can also lead to a T H 1 profile. Indeed, the large amounts of IL-12 produced by LAB-stimulated APCs contribute to this mechanism by activating signal transducer and activator of transcription (STAT) 4, which is known to transactivate IFN-γ directly. Moreover, Miettinen et al 27 demonstrated that gram-positive bacteria, such as GG, were able to indirectly induce STAT (mainly STAT1 and STAT3) DNA-binding activity in primary macrophages through cytokines, and following binding to the IFN-γ activation site element leads to IFN-γ production. In this way, in our experimental model, the production of IL-4 and IL-5 could be modulated.
Allergy was recently described as being the result of a deficit of bacterial stimulation during childhood. Our results confirm and extend previous observations that LAB might have a beneficial effect against allergic diseases by reducing T H 2 cytokine production. Consequently, LAB could restore the host capacity to limit the response against aeroallergens and the development of allergy.
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